Literature DB >> 31820270

Vaping-associated acute respiratory distress syndrome.

Nicole Marie Sakla1, Rishabh Gattu2, Gagandeep Singh2, Michael Sadler2.   

Abstract

Vaping-associated lung injury via the use of electronic nicotine delivery systems (ENDS) is currently being evaluated as a potential source of pulmonary injury with uncertain etiology as the use of tetrahydrocannabinol (THC) is increasing throughout the USA. ENDS are marketed to be unlike traditional cigarette smoking in that they are purported to contain only propylene glycol, vegetable glycerine, nicotine, and flavorants compared with the > 60 carcinogenic ingredients in cigarettes. The New England Journal of Medicine (NEJM) currently reports four imaging patterns correlated with vaping-attributed pathology including acute eosinophilic pneumonia, diffuse alveolar damage, organizing pneumonia, and lipoid pneumonia. The incidence and extent of lung disease in otherwise young healthy patients with a history of vaping has not however been definitively recognized within the field of radiology. We present a case of vaping-associated acute respiratory distress syndrome (ARDS) in a young patient with no additional past medical history. The immediate radiologic recognition of vaping as a risk factor for ARDS in the emergency setting is pivotal so that appropriate medical management and respiratory support can be initiated without delay.

Entities:  

Keywords:  ARDS; E-Cigarettes; ENDS; THC; Vaping

Year:  2019        PMID: 31820270     DOI: 10.1007/s10140-019-01736-6

Source DB:  PubMed          Journal:  Emerg Radiol        ISSN: 1070-3004


  15 in total

Review 1.  The pulmonary physician in critical care * 6: The pathogenesis of ALI/ARDS.

Authors:  G J Bellingan
Journal:  Thorax       Date:  2002-06       Impact factor: 9.139

2.  Web Exclusive. Annals On Call - Weighing the Potential Benefits and Harms of E-Cigarettes.

Authors:  Robert M Centor; Nancy A Rigotti
Journal:  Ann Intern Med       Date:  2019-02-05       Impact factor: 25.391

Review 3.  Fifty Years of Research in ARDS Why Is Acute Respiratory Distress Syndrome So Important for Critical Care?

Authors:  Luciano Gattinoni; Michael Quintel
Journal:  Am J Respir Crit Care Med       Date:  2016-11-01       Impact factor: 21.405

4.  Vaping-Induced Acute Lung Injury.

Authors:  David C Christiani
Journal:  N Engl J Med       Date:  2019-09-06       Impact factor: 91.245

Review 5.  Advances in understanding of the pathogenesis of acute respiratory distress syndrome.

Authors:  Charles Sharp; Ann B Millar; Andrew R L Medford
Journal:  Respiration       Date:  2015-04-25       Impact factor: 3.580

Review 6.  Overview of current lung imaging in acute respiratory distress syndrome.

Authors:  Maurizio Zompatori; Federica Ciccarese; Luca Fasano
Journal:  Eur Respir Rev       Date:  2014-12

Review 7.  Hazardous compounds in tobacco smoke.

Authors:  Reinskje Talhout; Thomas Schulz; Ewa Florek; Jan van Benthem; Piet Wester; Antoon Opperhuizen
Journal:  Int J Environ Res Public Health       Date:  2011-02-23       Impact factor: 3.390

8.  Acute respiratory distress syndrome: pathophysiology and therapeutic options.

Authors:  Charalampos Pierrakos; Menelaos Karanikolas; Sabino Scolletta; Vasilios Karamouzos; Dimitrios Velissaris
Journal:  J Clin Med Res       Date:  2012-01-17

9.  Respiratory bronchiolitis-associated interstitial lung disease secondary to electronic nicotine delivery system use confirmed with open lung biopsy.

Authors:  Mark Flower; Lakshmy Nandakumar; Mahendra Singh; David Wyld; Morgan Windsor; David Fielding
Journal:  Respirol Case Rep       Date:  2017-04-03

10.  Acute Respiratory Distress Syndrome: An Update and Review.

Authors:  Gautam Rawal; Sankalp Yadav; Raj Kumar
Journal:  J Transl Int Med       Date:  2018-06-26
View more
  7 in total

1.  Clinical and radiological characteristics of e-cigarette or vaping product use associated lung injury.

Authors:  Ambika G Chidambaram; Rebecca A Dennis; David M Biko; Marcus Hook; Julian Allen; Jordan B Rapp
Journal:  Emerg Radiol       Date:  2020-05-28

2.  Firsthand and Secondhand Exposure Levels of Maltol-Flavored Electronic Nicotine Delivery System Vapors Disrupt Amino Acid Metabolism.

Authors:  Zachery R Jarrell; Matthew Ryan Smith; Xiaojia He; Michael Orr; Dean P Jones; Young-Mi Go
Journal:  Toxicol Sci       Date:  2021-07-16       Impact factor: 4.849

3.  [Effect of intensity of smoking intoxication on severity parameters of acute exacerbations of chronic obstructive pulmonary disease treated in a hospital milieu].

Authors:  Ahmed Ben Saad; Ali Adhieb; Asma Migaou; Saousen Cheikh Mhamed; Nesrine Fahem; Naceur Rouatbi; Samah Joobeur
Journal:  Pan Afr Med J       Date:  2021-01-27

4.  Fundamentals of vaping-associated pulmonary injury leading to severe respiratory distress.

Authors:  Carolina Esquer; Oscar Echeagaray; Fareheh Firouzi; Clarissa Savko; Grant Shain; Pria Bose; Abigail Rieder; Sophie Rokaw; Andrea Witon-Paulo; Natalie Gude; Mark A Sussman
Journal:  Life Sci Alliance       Date:  2021-11-22

5.  Transcriptomic Evidence That Switching from Tobacco to Electronic Cigarettes Does Not Reverse Damage to the Respiratory Epithelium.

Authors:  Giovanna L Pozuelos; Meenakshi Kagda; Matine A Rubin; Maciej L Goniewicz; Thomas Girke; Prue Talbot
Journal:  Toxics       Date:  2022-07-04

6.  Acute Outcomes of Cigarette Smoke and Electronic Cigarette Aerosol Inhalation in a Murine Model.

Authors:  Pamela Félix da Silva; Natália Alves de Matos; Camila de Oliveira Ramos; Thalles de Freitas Castro; Natália Pereira da Silva Araújo; Ana Beatriz Farias de Souza; Guilherme de Paula Costa; Sílvia Dantas Cangussú; André Talvani; Akinori Cardozo Nagato; Frank Silva Bezerra
Journal:  Biomed Res Int       Date:  2022-09-22       Impact factor: 3.246

Review 7.  A Systematic Literature Review of E-Cigarette-Related Illness and Injury: Not Just for the Respirologist.

Authors:  Anna Tzortzi; Melpo Kapetanstrataki; Vaso Evangelopoulou; Panagiotis Beghrakis
Journal:  Int J Environ Res Public Health       Date:  2020-03-27       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.